TNF-α promotes CXCL-1/8 production in keratinocytes by downregulating galectin-3 through NF-κB and hsa-miR-27a-3p pathway to contribute psoriasis development

Immunopharmacol Immunotoxicol. 2023 Dec;45(6):692-700. doi: 10.1080/08923973.2023.2229510. Epub 2023 Jul 3.

Abstract

Objective: Treatment with TNF-α inhibitors improve psoriasis with minimize/minor neutrophils infiltration and CXCL-1/8 expression in psoriatic lesions. However, the fine mechanism of TNF-α initiating psoriatic inflammation by tuning keratinocytes is unclear. Our previous research identified the deficiency of intracellular galectin-3 was sufficient to promote psoriasis inflammation characterized by neutrophil accumulation. This study aims to investigate whether TNF-α participated in psoriasis development through dysregulating galectin-3 expression.

Methods: mRNA levels were assessed through quantitative real-time PCR. Flow cytometry was used to detect cell cycle/apoptosis. Western blot was used to evaluate the activation of the NF-κB signaling pathway. HE staining and immunochemistry were used to detect epidermal thickness and MPO expression, respectively. Specific small interfering RNA (siRNA) was used to knock down hsa-miR-27a-3p while plasmids transfection was used to overexpress galectin-3. Further, the multiMiR R package was utilized to predict microRNA-target interaction.

Results and discussion: We found that TNF-α stimulation altered cell proliferation and differentiation and promoted the production of psoriasis-related inflammatory mediators along with the inhibition of galectin-3 expression in keratinocytes. Supplement of galectin-3 could counteract the rise of CXCL-1/8 but not the other phenotypes of keratinocytes induced by TNF-α. Mechanistically, inhibition of the NF-κB signaling pathway could counteract the decrease of galectin-3 and the increase of hsa-miR-27a-3p expression whereas silence of hsa-miR-27a-3p could counteract the decrease of galectin-3 expression induced by TNF-α treatment in keratinocytes. Intradermal injection of murine anti-CXCL-2 antibody greatly alleviated imiquimod-induced psoriasis-like dermatitis.

Conclusion: TNF-α initiates psoriatic inflammation by increasing CXCL-1/8 in keratinocytes mediated by the axis of NF-κB-hsa-miR-27a-3p-galectin-3 pathway.

Keywords: CXCL-1/8; Psoriasis; TNF-α; galectin-3; keratinocytes.

MeSH terms

  • Animals
  • Chemokine CXCL1 / metabolism
  • Female
  • Galectin 3* / genetics
  • HaCaT Cells
  • Humans
  • Interleukin-8 / metabolism
  • Keratinocytes* / metabolism
  • Mice
  • Mice, Inbred C57BL
  • MicroRNAs* / genetics
  • NF-kappa B / metabolism
  • Psoriasis* / genetics
  • Psoriasis* / pathology
  • Signal Transduction
  • Tumor Necrosis Factor-alpha* / pharmacology

Substances

  • Tumor Necrosis Factor-alpha
  • MIRN27 microRNA, human
  • MicroRNAs
  • CXCL1 protein, human
  • CXCL8 protein, human
  • Chemokine CXCL1
  • Interleukin-8
  • Galectin 3
  • LGALS3 protein, human
  • NF-kappa B